跳至主要内容
临床试验/IRCT201506181760N41
IRCT201506181760N41已完成2 期

Evaluation of effect of consumption kafir probiotic on saliva count of candida albicans in chemotherapy patients

Vice Chancellor for Research and Technology, Babol University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 60 years(—)
性别
All

入选标准

  • Breast Cancer Patients with Cancer of the colon or candidate for chemotherapy; Patients aged twenty to sixty years with the same chemotherapy regimen
  • Exclusion criteria:
  • Patients with a history of chemotherapy and radiation therapy; Patients with atrophic tongue; Anemia; With mucocutaneous disease; The use of partial or full dentures;  With a history of oral diseases; People with underlying medical conditions (eg, diabetes, hypertension, etc.); Pregnant women; Smokers; The use of broad-spectrum antibiotics and anti-fungal drugs

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research and Technology, Babol University of Medical Sciences

相似试验